Fibroblast Activation Protein Inhibitor clinical trials

Explore recruiting fibroblast activation protein inhibitor clinical trials.

Recruiting fibroblast activation protein inhibitor studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Fibroblast Activation Protein Inhibitor trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

The use of [68Ga]Ga-FAPI PET/MRI in assessing disease activity in patients with Graves’ orbitopathy

Netherlands

Phase I and Phase II (Integrated)- Other EU CTIS Study details

"INDIGO-FAPI": Cutting Edge Imaging for Earlier Pancreatic Cancer Diagnosis: evaluation of Positron Emission Tomography (PET) with the Fibroblast Activation Protein Inhibitor (FAPI)

France

Phase I and Phase II (Integrated)- Other EU CTIS Study details

PET imaging of tumors with strong desmoplastic reaction in pancreas, bile ducts, ventricle and ovaries by a novel tracer, 68Ga-FAPI-46 = Fibroblast Activation Protein Inhibitor

Sweden, Finland

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 2, open-label, imaging study to explore the effects of sonelokimab in patients with active psoriatic arthritis or axial spondyloarthritis

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

Fibroblast Activation Protein Inhibitor trials by city

Fibroblast Activation Protein Inhibitor in Toronto Fibroblast Activation Protein Inhibitor in Vancouver Fibroblast Activation Protein Inhibitor in Montreal Fibroblast Activation Protein Inhibitor in Calgary Fibroblast Activation Protein Inhibitor in Edmonton Fibroblast Activation Protein Inhibitor in Ottawa Fibroblast Activation Protein Inhibitor in Winnipeg Fibroblast Activation Protein Inhibitor in Quebec City Fibroblast Activation Protein Inhibitor in Hamilton Fibroblast Activation Protein Inhibitor in Kitchener Fibroblast Activation Protein Inhibitor in London Fibroblast Activation Protein Inhibitor in Halifax Fibroblast Activation Protein Inhibitor in New York Fibroblast Activation Protein Inhibitor in Los Angeles Fibroblast Activation Protein Inhibitor in Chicago Fibroblast Activation Protein Inhibitor in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease